BeStock  
Stocks › Biotechnology › IONS

Ionis Pharmaceuticals IONS

US equityMarket cap rank #2142Biotechnology
$26.58 −$0.64 (-2.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.76 +0.68%
Open$26.93
Prev close$27.22
Day range$26.53 – $28.07
Volume3.19M
Market cap$4.43B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.7x
CheapRich

Near the top of its 5-year range · 89th percentile, 5-year average -104.3x

Price / book12.3x
CheapRich

Around its usual level · 48th percentile, 5-year average 14.9x

#5023 of 5331 stocks by PB (1 = cheapest)

Price / sales5.0x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 8.8x

#3950 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-2,518x-1,396x-274x848xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$80.00
Price vs. fair value-66.8%Trading below the estimate
Star rating★★★★★
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 12.29 – 14.86 48% (cheaper than usual) #5023 of 5331 (1 = cheapest)
PE -8.67 -8.00 -104.26 89% (pricier than usual) –
PS 5.04 4.93 8.84 0% (cheaper than usual) #3950 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on IONS.

Sign in to join the discussion.

Scroll to Top